Home / Import refusals / 112-8103330-3/1/1

FDA Import Refusal 112-8103330-3/1/1 — Square Pharmaceuticals PLC

Square Pharmaceuticals PLC — FEI 3003670128

The FDA refused shipment 112-8103330-3/1/1 from Square Pharmaceuticals PLC (Bangladesh) on August 15, 2012. The refused product falls under Drugs and Biologics — AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
August 15, 2012
Country
Bangladesh
Product Category
Drugs and Biologics
Product Code
62OCC14 AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II)
Charges
75

Recent inspections

  • 1157842 (VAI Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 915484 (NAI Fri Jan 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • AEK-9362789-9/20002/1 (Tue Mar 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9362789-9/10002/1 (Tue Mar 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9291931-3/60002/1 (Fri Jan 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7845871-6/20002/1 (Mon Nov 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Human Foods)
  • AEK-7455482-3/20002/1 (Fri Aug 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources